Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CCR2 | P41597 | 11/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9307258 | 0.94 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1CCR2POLBHTT | |
| SCHEMBL11674331 | 0.85 | — | — | |
| SCHEMBL3447071 | 0.83 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL5918218 | 0.82 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL2554781 | 0.82 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| Ammonia Solution, Strong SCHEMBL15049775 | 0.82 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL1278442 | 0.82 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL1290904 | 0.82 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL1653739 | 0.80 | L3MBTL1 (0.53) | L3MBTL1ALDH1A1CCR2RAB9APOLB | |
| SCHEMBL1162117 | 0.79 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1CCR2HTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1234828-A | Laundry pretreatment process and bleaching composition | PROCTER & GAMBLE (US) | 1999-11-10 | — | — | CN | claimed |
| CN-1198144-A | Bleaching compositions | PROCTER & GAMBLE (US) | 1998-11-04 | — | — | CN | claimed |
| WO-2023128495-A1 | POLYIMIDE PRECURSOR COMPOSITION WITH IMPROVED FLEXIBILITY AND ELONGATION | 피아이첨단소재 주식회사 | 2023-07-06 | — | — | WO | disclosed |
| CN-105518038-A | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | BASF SE | 2016-04-20 | — | — | CN | disclosed |
| EP-2039694-B1 | CGRP receptor antagonists | MERCK SHARP & DOHME (US) | 2014-03-26 | — | — | EP | disclosed |
| EP-1765805-B1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2013-11-20 | — | — | EP | disclosed |
| US-7893052-B2 | CGRP receptor antagonists | MERCK SHARP & DOHME LLC | 2011-02-22 | — | — | US | disclosed |
| US-20100298303-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-11-25 | — | — | US | disclosed |
| US-7772224-B2 | Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches | MERCK SHARP & DOHME CORP. (US) | 2010-08-10 | — | — | US | disclosed |
| US-7745427-B2 | CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2010-06-29 | — | — | US | disclosed |
| EP-1765805-A4 | CGRP RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2005072308-A2 | CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2005-08-11 | — | — | WO | disclosed |
| US-20040229861-A1 | CGRP receptor antagonists | MERCK SHARP & DOHME LLC | 2004-11-18 | — | — | US | disclosed |
| WO-2004092166-A2 | CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| CN-1238799-A | Soaker compositions | PROCTER & GAMBLE (US) | 1999-12-15 | — | — | CN | disclosed |
| CN-1234828-A | Laundry pretreatment process and bleaching composition | PROCTER & GAMBLE (US) | 1999-11-10 | — | — | CN | disclosed |
| CN-1198144-A | Bleaching compositions | PROCTER & GAMBLE (US) | 1998-11-04 | — | — | CN | disclosed |
| CN-1185800-A | Detergent composition comprising mutant amylase enzyme and oxygen bleaching agent | PROCTER & GAMBLE (US) | 1998-06-24 | — | — | CN | disclosed |
| CN-1038028-C | Granglar laundry bleaching composition | PROCTER & GAMBLE (US) | 1998-04-15 | — | — | CN | disclosed |
| CN-1131407-A | Granglar laundry bleaching composition | PROCTER & GAMBLE (US) | 1996-09-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229861-A1 | CGRP receptor antagonists | CCKBR, CCKAR, CALCRL | L3MBTL1 4078/4885ALDH1A1 3242/4885CCR2 477/4885 |
| US-20100298303-A1 | CGRP RECEPTOR ANTAGONISTS | CCKBR, BDKRB1, BDKRB2 | L3MBTL1 3490/4885ALDH1A1 3512/4885CCR2 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.